Klinika Ambroziak Estederm Sp. z o.o

Warsaw 02-953

0 studies enrolling now · 3 studies all time

What they study most

Dermatitis, Atopic, Plaque Psoriasis

Studies at this site

• A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis — Completed
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis — Stopped early